FDA Slaps Clinical Hold on Concert Pharma's Hair Loss Drug
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"FDA Slaps Clinical Hold on Concert Pharma's Hair Loss Drug" ALT"FDA Slaps Clinical Hold on Concert Pharma's Hair Loss Drug"May 17, 2017By Mark Terry, BioSpace.com Breaking News StaffThe…
<b>Mel-Mont Medical</b> Announces The Development Of M??a By XytoTest, A Self-Collected Cervical Sample That Seeks To Eradicate Cervical Cancer
Life Sciences Jobs ... Source: BioSpace
Cancer Biotech G1 Therapeutics Grabs $105 Million in IPO
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Cancer Biotech G1 Therapeutics Grabs $105 Million in IPO" ALT"Cancer Biotech G1 Therapeutics Grabs $105 Million in IPO"May 17, 2017By Alex Keown, BioSpace.com Breaking News StaffRALEIGH, N... Source:…
Enzymotec Reports First Quarter 2017 Unaudited Financial Results
Life Sciences Jobs ... Source: BioSpace
Why Pfizer May Need Another Big M&A for Growth
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x425-pfizer.jpg" NAME"Why Pfizer May Need Another Big M&A for Growth" ALT"Why Pfizer May Need Another Big M&A for Growth"May 17, 2017By Mark Terry, BioSpace.com Breaking News StaffCitis Andrew Baum<...…
Eleven Senate Democrats Warn Proposed Cuts Will Hurt Cures Act Implementation
In a letter sent Tuesday to President Trump, 11 Senate Democrats urged the White House to scrap plans for fiscal 2018 budget cuts that would affect implementation of the 21st…
FDA Issues 21 New Product-Specific Draft Guidances for Generics, 16 Revised
The FDA published 21 new and 16 revised product-specific draft guidances, outlining methods for establishing bioequivalence for generics. Source: Drug Industry Daily
J&J’s Blockbuster Diabetes Drug Invokana Receives Boxed Warning Over Amputation Risk
The FDA has issued a boxed warning for Johnson & Johnson’s Invokana (canagliflozin) treatment for type 2 diabetes, describing a doubled risk of leg and foot amputations compared to placebo.…
FDA Cites Florida Drugmaker for Serious Quality Violations
An FDA investigation into serous quality problems at a Florida pharmaceutical company revealed a litany of unsound practices in the manufacture of experimental drugs. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 447
- 448
- 449
- 450
- 451
- 452
- 453
- …
- 610
- Go to the next page